Disease: Familial hyperlipoproteinemia type 3
- A case report of an Egyptian family with familial hypercholesterolemia and an exonic LINE-1 insertion in LDLR
- A Clinical Case of Probable Sitosterolemia
- A novel equation for the estimation of low-density lipoprotein cholesterol in the Saudi Arabian population: a derivation and validation study
- A Pharmacologic Update: New Treatments for Patients with Cardiovascular Disease
- A Review of Progress on Targeting LDL Receptor-Dependent and -Independent Pathways for the Treatment of Hypercholesterolemia, a Major Risk Factor of ASCVD
- Actual nutrition in adults with familial hypercholesterolemia
- Acute pancreatitis risk in multifactorial chylomicronemia syndrome depends on the molecular cause of severe hypertriglyceridemia
- Alirocumab in Pediatric Patients With Heterozygous Familial Hypercholesterolemia: A Randomized Clinical Trial
- Analysis of the Correlation between FH and PCSK9 and APOB Gene Mutations in Han and Mongolian Populations of the Hulunbuir
- ANGPTL3 as a therapeutic target for treating homozygous familial hypercholesterolaemia: a shot in the arm for evinacumab
- Apolipoprotein C-III, familial chylomicronemia syndrome, and olezarsen
- Applicability of Diagnostic Criteria and High Prevalence of Familial Dysbetalipoproteinemia in Russia: A Pilot Study
- Association between Eating Patterns and Quality of Life in Patients with Familial Hypercholesterolemia
- Association Between Patient Sex and Familial Hypercholesterolemia and Long-Term Cardiovascular Risk Factor Management 5 Years After Acute Coronary Syndrome
- Barriers to and Facilitators of Implementing Guidelines for Detecting Familial Hypercholesterolaemia in Australia
- Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries
- Case Series of Genetically Confirmed Index Cases of Familial Hypercholesterolemia in Primary Care
- Characteristics of Coronary Atherosclerosis Related to Plaque Burden Regression During Treatment With Alirocumab: The ARCHITECT Study
- Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group
- Clinical profile, genetic spectrum and therapy evaluation of 19 Chinese pediatric patients with lipoprotein lipase deficiency
- Cluster analysis and visualisation of electronic health records data to identify undiagnosed patients with rare genetic diseases
- Communication: High-Density Lipoprotein-Specific Phospholipid Efflux in Familial Hypercholesterolemia
- Composition and distribution of lipoproteins after evolocumab in familial dysbetalipoproteinemia. A randomized controlled trial
- Cost-effectiveness and Return on Investment of a Nationwide Case-Finding Program for Familial Hypercholesterolemia in Children in the Netherlands
- CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing
- Current US prevalence of myocardial injury patterns and clinical outcomes among hospitalised patients with familial hypercholesterolaemia: insight from the National Inpatient Sample-a retrospective cohort study
- Diagnosis of Familial Hypercholesterolemia in Children and Young Adults
- Effect of omega-3 fatty acid ethyl esters on postprandial arterial elasticity in patients with familial hypercholesterolemia
- Etiology and emerging treatments for familial chylomicronemia syndrome
- Evinacumab and Cardiovascular Outcome in Patients With Homozygous Familial Hypercholesterolemia
- Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia
- Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy
- Evinacumab: Mechanism of action, clinical, and translational science
- Evolocumab Treatment in Pediatric Patients With Homozygous Familial Hypercholesterolemia: Pooled Data From Three Open-Label Studies
- Exchange Transfusion: A Good Option for the Acute Treatment of Familial Chylomicronemia Syndrome in the Neonatal Period
- Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study
- Familial Hypercholesterolemia and Our Family's Heart History: From Atherosclerosis and Angina to Awareness and Advocacy
- Familial hypercholesterolemia care by Dutch pediatricians-mind the gaps
- Familial hypercholesterolemia is related to cardiovascular disease, heart failure and atrial fibrillation. Results from a population-based study
- Familial Hypercholesterolemia Variant and Cardiovascular Risk in Individuals With Elevated Cholesterol
- Family cascade screening for equitable identification of familial hypercholesterolemia: study protocol for a hybrid effectiveness-implementation type III randomized controlled trial
- Genetic analysis and management of a familial hypercholesterolemia pedigree with polygenic variants: Case report
- Genetic association between vitamin D receptor gene and Saudi patients confirmed with Familial Hypercholesterolemia
- Genetic backgrounds and diagnosis of familial hypercholesterolemia
- Genetic Counseling and Genetic Testing for Familial Hypercholesterolemia
- Genetic identification of familial hypercholesterolemia within whole genome sequences in 6820 newborns
- Genetic Spectrum and Cascade Screening of Familial Hypercholesterolemia in Routine Clinical Setting in Hong Kong
- High Prevalence of Familial Hypercholesterolemia Due to the Founder Effect of the LDLR c.2271del Variant in Communities of Oaxaca, Mexico
- Identification and Functional Analysis of <em>APOB</em> Variants in a Cohort of Hypercholesterolemic Patients
- Identification and Molecular Characterization of a Novel Large-Scale Variant (Exons 4_18 Loss) in the LDLR Gene as a Cause of Familial Hypercholesterolaemia in an Italian Family
- Identification of pathogenic variants in the Brazilian cohort with Familial hypercholesterolemia using exon-targeted gene sequencing
- Impact of conducting a genetic study on the management of familial hypercholesterolemia
- Impact of the severe familial hypercholesterolemia status on atherosclerotic risks
- Improved lipid-lowering treatment and reduction in cardiovascular disease burden in homozygous familial hypercholesterolemia: The SAFEHEART follow-up study
- Improving the Detection of Potential Cases of Familial Hypercholesterolemia: Could Machine Learning Be Part of the Solution?
- Inclisiran: A New Strategy for LDL-C Lowering and Prevention of Atherosclerotic Cardiovascular Disease
- Increased FH-Risk-Score and Diabetes Are Cardiovascular Risk Equivalents in Heterozygous Familial Hypercholesterolemia
- Influence of triglyceride concentration in lipoprotein (a) as a function of dyslipidemia
- Knowledge, attitude, and practice of physicians towards familial hypercholesterolaemia in north regions of Saudi Arabia
- LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach
- Lipid Disorders and Pregnancy
- Lipidomic analysis identified potential predictive biomarkers of statin response in subjects with Familial hypercholesterolemia
- Long-term effects of volanesorsen on triglycerides and pancreatitis in patients with familial chylomicronaemia syndrome (FCS) in the UK Early Access to Medicines Scheme (EAMS)
- Long-Term LDL-Apheresis Treatment and Dynamics of Circulating miRNAs in Patients with Severe Familial Hypercholesterolemia
- Long-term outcomes of liver transplantation for homozygous familial hypercholesterolaemia in Australia and New Zealand
- Long-term safety and effectiveness of alirocumab and evolocumab in familial hypercholesterolemia (FH) in Belgium
- Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study
- Longer-Term Efficacy and Safety of Evinacumab in Patients With Refractory Hypercholesterolemia
- Longitudinal dynamics of circulating miRNAs in a swine model of familial hypercholesterolemia during early atherosclerosis
- Low-Cost High-Throughput Genotyping for Diagnosing Familial Hypercholesterolemia
- Membrane Transporter of Serotonin and Hypercholesterolemia in Children
- Monogenic hypertriglyceridemia and recurrent pancreatitis in a homozygous carrier of a rare APOA5 mutation: a case report
- Nailfold capillaroscopy reveals early peripheral microcirculation abnormalities in children affected by heterozygous familial hypercholesterolemia
- Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome
- Physical signs and atherosclerotic cardiovascular disease in familial hypercholesterolemia: the HELLAS-FH Registry
- Plasma legumain in familial hypercholesterolemia: associations with statin use and cardiovascular risk markers
- Population Genomic Screening for Three Common Hereditary Conditions : A Cost-Effectiveness Analysis
- Population screening shows risk of inherited cancer and familial hypercholesterolemia in Oregon
- Prevalence and factors associated with possible cases of familial hypercholesterolemia in Brazilian adults: a cross-sectional study
- Prevalence and management of familial hypercholesterolaemia in patients with chest pain admitted to hospital: a retrospective observational study
- Prevalence of FH-Causing Variants and Impact on LDL-C Concentration in European, South Asian, and African Ancestry Groups of the UK Biobank-Brief Report
- Prevalence, clinical features and prognosis of familial hypercholesterolemia in Chinese Han patients with acute coronary syndrome after a coronary event: a retrospective observational study
- Putative Pathogenic Variants of <em>ABCG5</em> and <em>ABCG8</em> of Sitosterolemia in Patients With Hyper-Low-Density Lipoprotein Cholesterolemia
- Real-World Effectiveness of PCSK9 Inhibitors in Reducing LDL-C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring Registries
- Recent advances in the management and implementation of care for familial hypercholesterolaemia
- Referral rate, profile and degree of control of patients with familial hypercholesterolemia: data from a single lipid unit from a Mediterranean area
- Relationship between lifestyle habits and cardiovascular risk factors in familial hypercholesterolemia
- Reporting LDL cholesterol results by clinical biochemistry laboratories in Czechia and Slovakia to improve the detection rate of familial hypercholesterolemia
- Resilient Older Subjects with Heterozygous Familial Hypercholesterolemia, Baseline Differences and Associated Factors
- Severe hypertriglyceridemia: Existing and emerging therapies
- Sex differences in trends and in-hospital outcomes of acute myocardial infarction in patients with familial hypercholesterolemia: insights from a large national database
- Subtyping Severe Hypercholesterolemia by Genetic Determinant to Stratify Risk of Coronary Artery Disease
- The diagnostic value of genetic testing in familial hypercholesterolemia in patients with premature myocardial infarction
- The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis
- The Health History of First-Degree Relatives' Dyslipidemia Can Affect Preferences and Intentions following the Return of Genomic Results for Monogenic Familial Hypercholesterolemia
- Treatment of pediatric heterozygous familial hypercholesterolemia 7 years after the EAS recommendations: Real-world results from a large French cohort
- Trends and hotspots in familial hypercholesterolemia: A bibliometric systematic review from 2002 to 2022
- Unveiling Familial Hypercholesterolemia-Review, Cardiovascular Complications, Lipid-Lowering Treatment and Its Efficacy
- Variability of longitudinal triglyceride phenotype in patients heterozygous for pathogenic APOA5 variants
- Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial